piperacillin--tazobactam-drug-combination and Respiratory-Distress-Syndrome--Newborn

piperacillin--tazobactam-drug-combination has been researched along with Respiratory-Distress-Syndrome--Newborn* in 1 studies

Reviews

1 review(s) available for piperacillin--tazobactam-drug-combination and Respiratory-Distress-Syndrome--Newborn

ArticleYear
Nosocomial pneumonia and sepsis caused by a rare organism
    BMJ case reports, 2019, Jul-11, Volume: 12, Issue:7

    A late preterm male infant of 36 weeks gestation and a birth weight of 2100 g was admitted on day 35 of life with complaints of respiratory distress and lethargy. He was diagnosed as a case of sepsis screen positive culture negative sepsis and was managed with respiratory support and intravenous antibiotics for 10 days. The infant improved clinically and was on spoon feeds by day 14 of admission. On day 14 of admission, he developed new-onset respiratory distress and was diagnosed as a case of nosocomial pneumonia based on chest radiography findings. The blood culture grew a rare organism

    Topics: Anti-Bacterial Agents; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infant; Lethargy; Male; Piperacillin, Tazobactam Drug Combination; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Sepsis; Spinal Puncture; Treatment Outcome

2019